Upgrade to SI Premium - Free Trial

Morgan Stanley on Pfizer (PFE): Atirmo Ph2 data an 'incremental positive'

March 17, 2026 8:39 AM
Morgan Stanley analyst Terence Flynn reiterated an Equalweight rating and $27.00 price target on Pfizer (NYSE: PFE)The analyst commented, "Atirmo ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments